PTx is dedicated to developing and commercializing innovative therapies that address significant unmet needs for patients. Building upon a strong foundation of expertise in oncology, PTx also leads and supports groundbreaking research in infectious disease and other areas of clinical urgency, including treatment of the novel coronavirus (COVID-19).
